Stock Events

Stock Events

Catalyst Pharmaceuticals 

$30.86
395
+$1.92+6.63% Tuesday 20:00

Statistics

Day High
30.97
Day Low
28.75
52W High
30.86
52W Low
19.13
Volume
2,635,452
Avg. Volume
-
Mkt Cap
3.77B
P/E Ratio
17.11
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.3
0.35
0.41
0.46
Expected EPS
0.456
Actual EPS
N/A

Financials

36.39%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.18BRevenue
428.65MNet Income

Analyst Ratings

35Average Price Target
The highest estimate is 35.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CPRX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap27.62B
Biogen focuses on neurology, a key area for Catalyst, making them direct competitors in treatments for neurological disorders.
AMGEN
AMGN
Mkt Cap178B
Amgen has a broad portfolio that includes treatments for neurological conditions, competing with Catalyst's offerings.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals engages in developing treatments for cystic fibrosis and other serious diseases, overlapping with Catalyst's target market.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals competes in the biopharmaceutical space, focusing on innovative treatments that could rival Catalyst's products.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.76B
ACADIA Pharmaceuticals focuses on central nervous system disorders, directly competing with Catalyst's product portfolio.
Ionis Pharmaceuticals
IONS
Mkt Cap12.44B
Ionis Pharmaceuticals develops RNA-targeted therapies, including for neurological diseases, competing with Catalyst's focus areas.
Sarepta Therapeutics
SRPT
Mkt Cap2.27B
Sarepta Therapeutics focuses on the discovery and development of RNA-based therapeutics, competing in the neuromuscular and rare disease space with Catalyst.

About

There is no Profile data available for CN2.SG.
Show more...
CEO
Mr. Patrick J. McEnany
Employees
181
Country
United States
ISIN
US14888U1016

Listings

MU
DE
CN2.MU
STU
DE
CN2.STU
BOATS
BOATS
CPRX.BOATS
F
DE
CN2.F

0 Comments

Share your thoughts

FAQ

What is Catalyst Pharmaceuticals stock price today?▼
The current price of CPRX is $30.86 USD — it has increased by +6.63% in the past 24 hours. Watch Catalyst Pharmaceuticals stock price performance more closely on the chart.
What is Catalyst Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Catalyst Pharmaceuticals stocks are traded under the ticker CPRX.
Is Catalyst Pharmaceuticals stock price growing?▼
CPRX stock has risen by +9.2% compared to the previous week, the month change is a +23.54% rise, over the last year Catalyst Pharmaceuticals has showed a +33.82% increase.
What is Catalyst Pharmaceuticals market cap?▼
Today Catalyst Pharmaceuticals has the market capitalization of 3.77B
When is the next Catalyst Pharmaceuticals earnings date?▼
Catalyst Pharmaceuticals is going to release the next earnings report on May 13, 2026.
What were Catalyst Pharmaceuticals earnings last quarter?▼
CPRX earnings for the last quarter are 0.41 USD per share, whereas the estimation was 0.34 USD resulting in a +19.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Catalyst Pharmaceuticals revenue for the last year?▼
Catalyst Pharmaceuticals revenue for the last year amounts to 1.18B USD.
What is Catalyst Pharmaceuticals net income for the last year?▼
CPRX net income for the last year is 428.65M USD.
How many employees does Catalyst Pharmaceuticals have?▼
As of May 06, 2026, the company has 181 employees.
In which sector is Catalyst Pharmaceuticals located?▼
Catalyst Pharmaceuticals operates in the Health & Wellness sector.
When did Catalyst Pharmaceuticals complete a stock split?▼
Catalyst Pharmaceuticals has not had any recent stock splits.
Where is Catalyst Pharmaceuticals headquartered?▼
Catalyst Pharmaceuticals is headquartered in Coral Gables, United States.